Moderna and Merck's mRNA cancer vaccine cuts death, recurrence by 42%
Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.

Loading the Newsroom
Curating from trusted global sources…
67 briefings · “anc”
Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.
Musk's reported stake lands alongside Laurene Powell Jobs as the $111bn Paramount-WBD merger redraws Hollywood.
Heavy AI spending is squeezing the carmaker's bottom line, and a SpaceX tie-up would put two Musk giants on one balance sheet.
Tesla's safety reel shows Waymo and Avride cutting into its lane, a subtle jab ahead of earnings and the Dallas Cybercab launch.
A mycologist's frozen Edinburgh garden became the backdrop for vivid views inside cells, a reminder of what advanced imaging now makes visible to researchers and the industries built on biology.
Special committees at both companies will examine a tie-up that could fuse electric vehicles and space launch, forcing a fresh look at governance and valuation.
The server maker says revenue and profit could land far above guidance, lifting the whole AI hardware complex and raising stakes for upcoming earnings.
A new University of Mississippi and Cornell review finds precision weed tools can replace chemicals and labor, yet adoption comes with serious financial and operational hurdles.
A 10,000-person study finds standard antidepressants often fail these patients, but melatonin and morning sunlight may hit the real root cause.
The CEO of both companies is a 'conflicted party' watching independent directors negotiate a tie-up that would create a $3.5 trillion giant he would own about a third of.
The streaming giant's earnings beat couldn't offset investor worries about its advertising business and softer revenue outlook.
AI meeting notetaker lands $320M to chase enterprise deals and global expansion.